Please ensure Javascript is enabled for purposes of website accessibility
Главная > Продукты > Антитела > Биосимиляры

Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO) (HV681016)

Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)
Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)
Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)
Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)
Цена(USD):
Спецификация:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Количество:
Свяжитесь с нами
  • Обзор

  • Изображения

  • Ссылки

  • Даташит

  • SDS

Обзор
Каталожный номерHV681016
Описание
Ontuxizumab (HV681016) is a research-grade recombinant antibody targeting CD164L. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Реактивность видовHuman
ПримененияELISA, Bioactivity: FACS, Functional assay, Research in vivo
Хозяинский видHuman
КлоональностьMonoclonal
ИзотипIgG1-kappa
Система экспрессии Mammalian cells
Цель Endosialin, TEM1, CD164L1, Tumor endothelial marker 1, CD248
Уровень эндотоксинов < 10 EU/mg
Чистота >95% purity as determined by SDS-PAGE.
Очистка Protein A/G purified from cell culture supernatant.
Номер доступа Q9HCU0
Форма Liquid
Буфер хранения 0.01M PBS pH 7.4

Пожалуйста, обратитесь к конкретной информации о буфере в печатной версии даташита или в индивидуальном сертификате качества (COA) для партии.

Устойчивость и хранение Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Альтернативные названияMORAb-004, 946415-62-9
Фон

Endosialin (CD248) is a ~80 kDa protein. Cell surface glycoprotein involved in various biological processes including angiogenesis, immune response modulation, and tissue remodeling and repair. Participates in pericyte proliferation through positive modulation of the PDGF receptor signaling pathway. Acts as a scaffold for factor X, triggering allosteric changes and the spatial re-alignment of factor X with the TF-factor VIIa complex, thereby enhancing coagulation activation. Modulates the insulin signaling pathway by interacting with insulin receptor/INSR and by diminishing its capacity to be autophosphorylated in response to insulin. Also regulates LPS-induced inflammatory response in macrophages by favoring the production of proinflammatory cytokines.

1. Tomkowicz, B. et al. (2010) Cancer biology & therapy 9, 908-15. PMID: 20484976
2. Hardie, DL. et al. (2011) Immunology 133, 288-95. PMID: 21466550
Примечание For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 (LALA) Recombinant Isotype Control Antibody (HyHEL-10) (HP688107)
Изображения
  • Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Ontuxizumab.

  • Anti-Human Endosialin/CD248 Reference Antibody (Ontuxizumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Ontuxizumab

Ссылки
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Рекомендация

Свяжитесь с нами для индивидуальных предложений, оптовых запросов и других вопросов.

Почта: [email protected]

Список дистрибьюторов